Company Valuation: Clarity Medical Group Holding Limited

Data adjusted to current consolidation scope
Fiscal Period: March 2022 2023 2024
Market Cap 1 637.1 496.4 359.1
Change - -22.08% -27.66%
Enterprise Value (EV) 1 416.1 336.2 243.1
Change - -19.19% -27.69%
P/E 36.2x -154x -4.71x
PBR 2.49x 1.91x 1.89x
PEG -0.6x 1x -0x
Capitalization / Revenue 2.83x 2.32x 1.88x
EV / Revenue 1.85x 1.57x 1.27x
EV / EBITDA 9.63x -218x -6.03x
EV / EBIT 11.7x -43.5x -4.32x
EV / FCF - - -
FCF Yield - - -
Dividend per Share 2 - - -
Rate of return - - -
EPS 2 0.0346 -0.006108 -0.1444
Distribution rate - - -
Net sales 1 225.2 213.8 190.9
EBITDA 1 43.19 -1.543 -40.34
EBIT 1 35.49 -7.722 -56.23
Net income 1 13.49 -3.191 -75.79
Net Debt 1 -221.1 -160.2 -116
Reference price 2 1.2500 0.9400 0.6800
Nbr of stocks (in thousands) 509,718 528,125 528,125
Announcement Date 27/7/22 28/7/23 26/7/24
1HKD in Million2HKD
Estimates


P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 24.29M
32.15x2.98x13.39x1.37% 18.11B
51.54x4.43x28.85x0.27% 13.45B
18.87x2.25x10.49x0.66% 11.86B
25.68x2.97x10.3x1.56% 11.32B
85.95x7.92x32.6x - 10.55B
24.4x1.98x15.98x0.16% 9.96B
19.47x2.81x11.65x4.18% 9.39B
39.14x1.02x8.49x1.66% 8.46B
13.2x1.33x8.01x2.1% 8.05B
Average 34.49x 3.08x 15.53x 1.49% 10.11B
Weighted average by Cap. 35.19x 3.19x 16.02x 1.39%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA


  1. Stock Market
  2. Stocks
  3. 1406 Stock
  4. Valuation Clarity Medical Group Holding Limited